• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.

作者信息

Shapeton Alexander D, Mahmood Feroze, Ortoleva Jamel P

机构信息

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA.

出版信息

J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.

DOI:10.1053/j.jvca.2018.08.017
PMID:30217583
Abstract
摘要

相似文献

1
Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.羟钴胺素治疗血管麻痹：当前文献综述及使用考量
J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.
2
Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.羟钴胺素（维生素 B12a）在体外循环后血管加压药抵抗性低血压患者中的应用：病例系列。
Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648.
3
Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.心脏手术后患有血管麻痹综合征的危重症患者使用或不使用亚甲蓝的羟钴胺素可能改善液体平衡：两例报告
J Cardiothorac Vasc Anesth. 2018 Feb;32(1):452-457. doi: 10.1053/j.jvca.2017.04.002. Epub 2017 Apr 5.
4
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.亚甲蓝单药治疗与羟钴胺联合治疗难治性血管扩张性休克的疗效比较：一项回顾性队列研究。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1301-1307. doi: 10.1053/j.jvca.2018.11.020. Epub 2018 Nov 16.
5
Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.用于肝移植中血管麻痹综合征的羟钴胺：恢复血压且无血管痉挛
A A Case Rep. 2016 Dec 15;7(12):247-250. doi: 10.1213/XAA.0000000000000398.
6
Elevated Serum Cobalt Concentrations Associated With Hydroxocobalamin Administration for Refractory Vasoplegia.与使用羟钴胺治疗难治性血管麻痹相关的血清钴浓度升高
J Cardiothorac Vasc Anesth. 2019 Dec;33(12):3402-3405. doi: 10.1053/j.jvca.2019.08.013. Epub 2019 Aug 17.
7
Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。
Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.
8
The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.静脉注射羟钴胺素在心脏手术中对亚甲蓝抵抗性血管麻痹综合征的抢救应用。
Ann Card Anaesth. 2017 Oct-Dec;20(4):462-464. doi: 10.4103/aca.ACA_88_17.
9
Hydroxocobalamin as a Rescue Treatment for Refractory Vasoplegic Syndrome After Prolonged Cardiopulmonary Bypass.羟钴胺作为长时间体外循环后难治性血管麻痹综合征的抢救治疗方法。
J Cardiothorac Vasc Anesth. 2017 Jun;31(3):1012-1014. doi: 10.1053/j.jvca.2016.08.019. Epub 2016 Aug 18.
10
Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.静脉注射羟钴胺素治疗肝肾联合移植中血管扩张性综合征：一例报告。
Transplant Proc. 2021 May;53(4):1300-1302. doi: 10.1016/j.transproceed.2020.09.019. Epub 2020 Nov 24.

引用本文的文献

1
Variable Toxicity by β-Blocker Class in Intentional Overdoses Reported To U.S. Poison Centers.向美国毒物控制中心报告的β受体阻滞剂类药物故意过量服用的可变毒性。
J Med Toxicol. 2025 Jul 31. doi: 10.1007/s13181-025-01088-3.
2
Management of hypotension in dihydropyridine calcium channel blocker overdose: The role of high-dose insulin therapy.二氢吡啶类钙通道阻滞剂过量导致低血压的处理：大剂量胰岛素疗法的作用
Br J Clin Pharmacol. 2025 Sep;91(9):2613-2620. doi: 10.1002/bcp.70081. Epub 2025 Apr 27.
3
Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series.
羟钴胺素治疗肺移植术后血管麻痹：病例系列
JHLT Open. 2024 Nov 29;7:100189. doi: 10.1016/j.jhlto.2024.100189. eCollection 2025 Feb.
4
Management of vasoplegic shock.血管麻痹性休克的管理
BJA Educ. 2025 Feb;25(2):65-73. doi: 10.1016/j.bjae.2024.10.004. Epub 2024 Dec 9.
5
Hydroxocobalamin treatment for refractory hypotension and shock: a case series.羟钴胺治疗难治性低血压和休克：病例系列
Can J Anaesth. 2025 Jan;72(1):208-210. doi: 10.1007/s12630-024-02881-4. Epub 2024 Dec 16.
6
Skin injury: Associations with variables related to perfusion and pressure.皮肤损伤：与灌注和压力相关变量的关系。
Anaesth Intensive Care. 2024 Nov;52(6):386-396. doi: 10.1177/0310057X241264575. Epub 2024 Oct 12.
7
Severe Refractory Vasoplegic Shock Syndrome after OPCABG Successfully Treated with Hydroxycobalamin: A Case Report and Review of the Literature.羟钴胺成功治疗非体外循环冠状动脉搭桥术后严重难治性血管麻痹性休克综合征：一例报告并文献复习
J Clin Med. 2023 Dec 28;13(1):169. doi: 10.3390/jcm13010169.
8
Antidotes in Clinical Toxicology-Critical Review.《临床毒理学中的解毒剂——批判性综述》
Toxics. 2023 Aug 23;11(9):723. doi: 10.3390/toxics11090723.
9
Vasoplegic Syndrome and Anaesthesia: A Narrative Review.血管麻痹综合征与麻醉：一篇叙述性综述
Turk J Anaesthesiol Reanim. 2023 Aug 18;51(4):280-289. doi: 10.4274/TJAR.2023.221093.
10
Ketamine, interleukin-6, and vasoplegia: Is prevention the best medicine?氯胺酮、白细胞介素-6与血管麻痹：预防是最佳疗法吗？
Ann Card Anaesth. 2023 Jan-Mar;26(1):114-116. doi: 10.4103/aca.aca_31_21.